Workflow
Shareholder rights
icon
Search documents
HALPER SADEH LLC ENCOURAGES SEMTECH CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Prnewswire· 2025-11-30 20:10
Core Viewpoint - Halper Sadeh LLC is investigating potential breaches of fiduciary duties by certain officers and directors of Semtech Corporation, which may affect shareholder rights and corporate governance [1][2]. Group 1: Shareholder Rights and Legal Options - Long-term shareholders of Semtech may seek corporate governance reforms, return of funds, court-approved financial incentives, or other benefits [2]. - Shareholder involvement is crucial for improving company policies and practices, leading to enhanced transparency and accountability, which can ultimately increase shareholder value [3]. Group 2: Firm's Background and Services - Halper Sadeh LLC represents global investors affected by securities fraud and corporate misconduct, having successfully implemented corporate reforms and recovered millions for defrauded investors [4].
HALPER SADEH LLC ENCOURAGES THE BEAUTY HEALTH COMPANY SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Prnewswire· 2025-11-30 20:07
Core Viewpoint - Halper Sadeh LLC is investigating potential breaches of fiduciary duties by certain officers and directors of The Beauty Health Company, which may affect shareholder rights and corporate governance [1][2]. Group 1: Shareholder Rights and Legal Options - Long-term shareholders of Beauty Health may seek corporate governance reforms, financial incentives, or other benefits through legal action [2]. - Shareholder involvement is emphasized as a means to improve company policies and enhance shareholder value [3]. Group 2: Firm's Background and Services - Halper Sadeh LLC represents global investors affected by securities fraud and corporate misconduct, having recovered millions for defrauded investors [4].
HALPER SADEH LLC ENCOURAGES AMYLYX PHARMACEUTICALS, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Prnewswire· 2025-11-28 23:40
Core Points - Halper Sadeh LLC is investigating potential breaches of fiduciary duties by certain officers and directors of Amylyx Pharmaceuticals, Inc. [1] - Long-term shareholders of Amylyx may seek corporate governance reforms, financial incentives, or other benefits through legal action [2] - Shareholder involvement is emphasized as a means to improve company policies and enhance shareholder value [3] - Halper Sadeh LLC has a history of representing investors affected by securities fraud and corporate misconduct, recovering millions for defrauded investors [4]
HALPER SADEH LLC ENCOURAGES DANAHER CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Prnewswire· 2025-11-28 23:34
Core Viewpoint - Halper Sadeh LLC is investigating potential breaches of fiduciary duties by certain officers and directors of Danaher Corporation, which may affect shareholder rights and corporate governance [1][2]. Group 1: Shareholder Rights and Legal Options - Long-term shareholders of Danaher may seek corporate governance reforms, return of funds, court-approved financial incentives, or other benefits [2]. - Shareholder involvement is crucial for improving company policies and practices, leading to enhanced shareholder value [3]. Group 2: Firm's Background and Services - Halper Sadeh LLC represents global investors affected by securities fraud and corporate misconduct, having successfully implemented corporate reforms and recovered significant funds for defrauded investors [4].
Halper Sadeh LLC Encourages AXTA, SEMR, CDTX Shareholders to Contact the Firm to Discuss Their Rights
Globenewswire· 2025-11-27 23:52
Core Insights - Halper Sadeh LLC is investigating potential violations of federal securities laws and breaches of fiduciary duties related to the sales of Axalta Coating Systems Ltd., Semrush Holdings, Inc., and Cidara Therapeutics, Inc. [1][2] Group 1: Company Transactions - Axalta Coating Systems Ltd. is being sold to Akzo Nobel N.V. for 0.6539 shares of AkzoNobel stock for each share of Axalta common stock [1] - Semrush Holdings, Inc. is being sold to Adobe for $12.00 per share [2] - Cidara Therapeutics, Inc. is being sold to Merck for $221.50 per share in cash [2] Group 2: Legal Actions and Shareholder Rights - Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures, and other relief on behalf of shareholders [3] - Shareholders are encouraged to contact Halper Sadeh LLC to discuss their legal rights and options [4]
Bragar Eagel & Squire, P.C. Urges DexCom and Wildermuth Investors to Contact the Firm Regarding Their Rights
Globenewswire· 2025-11-26 00:15
Core Viewpoint - Class actions have been initiated on behalf of stockholders of DexCom, Inc. and Wildermuth Fund, with deadlines for investors to petition the court to serve as lead plaintiff [1]. DexCom, Inc. (NASDAQ:DXCM) - The class action alleges that during the class period from January 8, 2024, to September 17, 2025, DexCom made materially false and misleading statements regarding its business and compliance policies [6]. - Specific allegations include unauthorized design changes to the G6 and G7 devices that rendered them less reliable, presenting health risks to users [6]. - The complaint claims that the enhancements to the G7 were overstated and that the true scope of issues with the devices was downplayed, leading to increased regulatory scrutiny and potential legal and financial harm [6]. Wildermuth Fund (NASDAQ:WEFCX, NASDAQ:WESFX, NASDAQ:WEIFX) - The class action for Wildermuth Fund covers the period from November 1, 2020, to June 29, 2023, with a lead plaintiff deadline of December 29, 2025 [6]. - Allegations include miscalculating the fair value of the Fund's investments and failing to disclose financial support for portfolio companies with questionable viability [6]. - The complaint also states that the Fund intentionally inflated its net asset value, resulting in excessive advisory fees, which harmed class members [6].
Shareholder Alert: The Ademi Firm investigates whether Semrush Holdings Inc. is obtaining a Fair Price for its Public Shareholders
Prnewswire· 2025-11-19 18:10
Core Viewpoint - The Ademi Firm is investigating Semrush for potential breaches of fiduciary duty and other legal violations related to its transaction with Adobe, which involves a cash payment of $12.00 per share, valuing the deal at approximately $1.9 billion [1][2][3]. Group 1: Transaction Details - Semrush shareholders will receive $12.00 per share in an all-cash transaction valued at approximately $1.9 billion [2]. - The transaction agreement includes provisions that significantly limit competing offers for Semrush, imposing penalties if a competing bid is accepted [3]. Group 2: Investigation Focus - The investigation is centered on the conduct of Semrush's board of directors to determine if they are fulfilling their fiduciary duties to all shareholders [3]. - The Ademi Firm specializes in shareholder litigation concerning buyouts, mergers, and individual shareholder rights [4].
Johnson Fistel Investigates Semrush (SEMR) Shareholders' Rights Following Adobe's $12 Buyout Offer
Globenewswire· 2025-11-19 17:07
Core Viewpoint - Johnson Fistel, PLLP has initiated an investigation into potential breaches of fiduciary duties by the board members of Semrush Holdings, Inc. regarding the proposed sale of the company to Adobe, Inc. [1] Company Overview - Semrush Holdings, Inc. has entered into a definitive merger agreement with Adobe, where shareholders will receive $12.00 per share in cash for each share of common stock owned [6] - The proposed acquisition price of $12.00 per share is below Semrush's 52-week high of $18.74, and a Wall Street analyst has set a target price of $21 per share [6] Legal Context - The investigation by Johnson Fistel focuses on whether the proposed transaction undervalues Semrush shares, and shareholders are encouraged to participate in the investigation if they believe their investment is undervalued [2]
Johnson Fistel Investigates Potential Board Fiduciary Duty Breaches in the Sealed Air Buyout
Globenewswire· 2025-11-17 17:19
Core Viewpoint - Johnson Fistel, PLLP has initiated an investigation into potential breaches of fiduciary duties by the board members of Sealed Air Corporation regarding the proposed acquisition by CD&R, which is perceived to undervalue the company’s shares [1][2]. Group 1: Company Overview - Sealed Air Corporation has entered into a definitive merger agreement with CD&R, where CD&R will acquire all outstanding shares of Sealed Air common stock for $42.15 per share in cash [2]. Group 2: Legal Firm Background - Johnson Fistel, PLLP is a nationally recognized shareholder-rights law firm with multiple offices across the United States, representing both individual and institutional investors in securities class action lawsuits [3]. Group 3: Achievements of the Law Firm - In 2024, Johnson Fistel was ranked among the Top 10 Plaintiff Law Firms by ISS Securities Class Action Services, having recovered approximately $90.725 million for clients in cases where it served as lead or co-lead counsel [4].
Shareholder Alert: The Ademi Firm investigates whether TreeHouse Foods Inc. is obtaining a Fair Price for its Public Shareholders
Prnewswire· 2025-11-10 16:24
Core Viewpoint - The Ademi Firm is investigating TreeHouse Foods for potential breaches of fiduciary duty and other legal violations related to its transaction with Investindustrial, which involves a cash payment and contingent value rights for shareholders [1][3]. Transaction Details - TreeHouse Foods shareholders will receive $22.50 per share in cash, amounting to an equity value of $1.2 billion, along with one contingent value right per share that entitles holders to 85% of net proceeds from ongoing litigation against Keurig Green Mountain concerning antitrust claims in the single-serve coffee market [2]. - The transaction includes significant benefits for TreeHouse Foods insiders as part of change of control arrangements [2]. Board Conduct - The transaction agreement imposes a significant penalty on TreeHouse Foods for accepting competing bids, which raises concerns about the board of directors' fulfillment of their fiduciary duties to all shareholders [3].